PRELUDE CAPITAL MANAGEMENT, LLC - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 53 filers reported holding NEON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$0
-100.0%
119
-10.5%
0.00%
Q2 2019$1,0000.0%133
-6.3%
0.00%
Q1 2019$1,000
-92.9%
142
-91.4%
0.00%
-100.0%
Q3 2018$14,0001,6420.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$25,718,0007.00%
HARVARD MANAGEMENT CO INC 505,871$1,335,0000.21%
ARMISTICE CAPITAL, LLC 1,050,000$2,772,0000.17%
Maven Securities LTD 381,150$1,006,0000.12%
Athanor Capital, LP 547,651$1,446,0000.09%
MONETA GROUP INVESTMENT ADVISORS LLC 102,652$271,0000.03%
TERRIL BROTHERS, INC. 19,300$51,0000.02%
MEEDER ASSET MANAGEMENT INC 5,878$15,0000.00%
ACADIAN ASSET MANAGEMENT LLC 94,908$251,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEON THERAPEUTICS INC shareholders